Clinical Study

Changes and Diurnal Variation of Visual Quality after Orthokeratology in Myopic Children

Table 4

Effects of orthokeratology on ocular aberrations (, mean ± SD).

TimeComaTrefoilTetrafoilSphS3S4S5S6S7S8

3 mm optical zone
Baseline AM0.019 ± 0.010.044 ± 0.020.023 ± 0.01−0.004 ± 0.010.050 ± 0.020.028 ± 0.010.017 ± 0.010.017 ± 0.010.013 ± 0.010.011 ± 0.01
1 month AM0.049 ± 0.030.077 ± 0.040.037 ± 0.020.019 ± 0.020.099 ± 0.040.050 ± 0.020.029 ± 0.020.025 ± 0.020.018 ± 0.010.015 ± 0.01
1 month PM0.052 ± 0.030.081 ± 0.050.030 ± 0.030.023 ± 0.010.101 ± 0.060.046 ± 0.030.027 ± 0.020.019 ± 0.010.015 ± 0.010.013 ± 0.01
P1<0.0010.0020.005<0.001<0.001<0.001<0.0010.110.0810.235
P20.6180.6650.2160.030.7990.3310.7520.2330.4090.428

4 mm optical zone
Baseline AM0.043 ± 0.020.081 ± 0.030.035 ± 0.02−0.010 ± 0.020.095 ± 0.030.047 ± 0.020.033 ± 0.010.028 ± 0.010.022 ± 0.010.018 ± 0.01
1 month AM0.196 ± 0.090.136 ± 0.080.072 ± 0.030.099 ± 0.060.256 ± 0.100.143 ± 0.060.087 ± 0.040.060 ± 0.030.039 ± 0.030.033 ± 0.03
1 month PM0.210 ± 0.080.145 ± 0.080.062 ± 0.050.108 ± 0.040.264 ± 0.100.141 ± 0.060.083 ± 0.050.046 ± 0.020.031 ± 0.020.026 ± 0.02
P1<0.0010.005<0.001<0.001<0.001<0.001<0.0010.0010.0070.017
P20.1580.6340.4170.140.5870.8390.6720.1160.2820.329

5 mm optical zone
Baseline AM0.091 ± 0.050.129 ± 0.040.059 ± 0.03−0.019 ± 0.050.166 ± 0.050.091 ± 0.040.064 ± 0.030.047 ± 0.030.039 ± 0.020.032 ± 0.02
1 month AM0.532 ± 0.260.223 ± 0.100.120 ± 0.060.333 ± 0.160.603 ± 0.260.393 ± 0.150.181 ± 0.090.112 ± 0.050.082 ± 0.050.065 ± 0.04
1 month PM0.540 ± 0.240.222 ± 0.100.093 ± 0.070.328 ± 0.140.602 ± 0.240.373 ± 0.140.157 ± 0.080.095 ± 0.050.074 ± 0.040.051 ± 0.03
P1<0.001<0.001<0.001<0.001<0.001<0.001<0.001<0.0010.0010.002
P20.7620.9690.1810.730.9680.2240.2380.2330.5360.213

Paired t-test. P1: comparison between AM baseline and AM 1 month after orthokeratology; P2: comparison between AM and PM during the same day 1 month after orthokeratology.